What is PPCM & The LAB Center Goals

A leading research study group in North America, IPAC Labs (Investigations of Pregnancy Associated Cardiomyopathy) is funded by the United States National Heart, Lung, and Blood Institute of the National Institution of Health (NIH); IPAC have recently documented improved possible recovery levels of PPCM to greater than 90% of victims when diagnosis can be made in the early stages. IPAC Labs have been working tirelessly and is now expanding their study to an amazing 50 medical centers in the USA and Canada, up from the current 30 and is directed by Dr. Dennis M. McNamara, Cardiologist, at the University of Pittsburgh Medical Center. Again, we believe that no mother should die from PPCM and that every PPCM mother should be able to fully recover and experience their child. The goal is within our reach; we need your help.

We want to know what causes Peripartum Cardiomyopathy on a molecular level. IPAC case studies provide us with a leading-edge look into the underlying causes of PPCM and how to further prevent the disease. While the direct underlying cause is still unknown, there are ways to prevent full blown cardiac arrest and mortality if caught in time.

Heart failure in young women related to pregnancy is called Peripartum Cardiomyopathy (PPCM) or pregnancy-associated-cardiomyopathy (PAC). PPCM occurs all over the world and is one of the leading causes of maternal mortality and is reported in roughly 1 in 2000 pregnancies. Even women in PERFECT health can develop PPCM.

The cure: "Raise The Standard Screening, Testing and Labs" — implementing the Pro B-Type natriuretic peptide (NT-pro BNP-BPN) & (EKG) Echocardiograms as mandatory treatments of care during and after all pregnancies. Early diagnosis saves lives!

PPCM holds no discrimination toward age, race or heritage, etc. however, incidences seem to be twice as common in African & Black-Americans compared to other races and nationalities.